Skip to main content
Synbiotic SE logo

Synbiotic SE — Investor Relations & Filings

Ticker · SBX ISIN · DE000A3E5A59 LEI · 48510041U2G1IWA3R418 F Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2026-04-08 Regulatory Filings
Country DE Germany
Listing F SBX

About Synbiotic SE

https://www.synbiotic.com/

Synbiotic SE is a European corporate group focused on the medical cannabis and industrial hemp markets. The company operates a platform model, making strategic investments in ventures across these sectors to create synergies. Its business is vertically integrated, covering the entire value chain from cultivation, research, and development to the production, sales, and distribution of hemp- and cannabinoid-based products. The company's portfolio includes a wide range of high-quality hemp, CBD, and cannabis products, leveraging its expertise across the full supply chain from seed to shelf.

Recent filings

Filing Released Lang Actions
SYNBIOTIC enters spring 2026 with operational progress, new regulatory momentum, and strong industry event presence
Regulatory Filings Classification · 85% confidence The document is a corporate news press release (operational and regulatory updates) by SYNBIOTIC SE, not a financial results announcement, earnings release, or detailed investor presentation. It does not report quarterly or annual results, board changes, capital raising, M&A, or other specific events fitting our specialized categories. As a general corporate announcement, it falls under the fallback category Regulatory Filings (RNS).
2026-04-08 English
Global momentum in the cannabis market: New signals from the U.S. strengthen long-term prospects for Europe and SYNBIOTIC
Regulatory Filings Classification · 95% confidence The document is a corporate news release issued by SYNBIOTIC SE regarding the impact of U.S. cannabis policy changes on the company's market prospects. It does not constitute a formal financial report, audit, or regulatory filing, but rather a press release/corporate news update. As it does not fit into specific categories like earnings releases or M&A, it falls under the general regulatory announcement/corporate news category.
2026-01-21 English
SYNBIOTIC SE: DURCHFUHRUNG EINER KAPITALERHOHUNG BESCHLOSSEN
Share Issue/Capital Change Classification · 100% confidence The document is an ad-hoc announcement regarding a capital increase (Kapitalerhöhung) by SYNBIOTIC SE. It details the decision to issue new shares, the subscription price, and the purpose of the capital raise. This falls directly under the category of share issuance and capital changes.
2025-12-17 German
Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
Capital/Financing Update Classification · 95% confidence The document is a corporate news announcement regarding a strategic equity investment where CANSOUL acquired a stake in SYNBIOTIC SE via a cash capital increase. While it involves a capital increase, the primary nature of the document is a press release/corporate news announcement detailing the partnership and investment, which falls under the 'Regulatory Filings' (RNS) category as it is a general corporate news dissemination via the EQS service.
2025-12-16 English
SYNBIOTIC SE: Bushdoctor GmbH beantragt Insolvenzverfahren
Regulatory Filings Classification · 98% confidence The document is an 'Ad-hoc' announcement (insider information) under Article 17 of the EU Market Abuse Regulation (MAR) regarding a subsidiary filing for insolvency. It does not fit into specific categories like M&A, dividends, or director dealings. As it is a regulatory disclosure of a material event that does not fall into the other specialized categories, it is classified as a general regulatory filing (RNS).
2025-12-12 German
SYNBIOTIC SE: DURCHFUHRUNG EINER KAPITALERHOHUNG BESCHLOSSEN
Share Issue/Capital Change Classification · 100% confidence The document is an ad-hoc announcement regarding a capital increase (Kapitalerhöhung) by SYNBIOTIC SE. It details the decision to issue new shares, the exclusion of subscription rights, and the placement price. This falls directly under the category of share issuance and capital changes.
2025-12-11 German

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.